1. Home
  2. IMNM vs MATV Comparison

IMNM vs MATV Comparison

Compare IMNM & MATV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • MATV
  • Stock Information
  • Founded
  • IMNM 2006
  • MATV 1995
  • Country
  • IMNM United States
  • MATV United States
  • Employees
  • IMNM N/A
  • MATV N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • MATV Paper
  • Sector
  • IMNM Health Care
  • MATV Basic Materials
  • Exchange
  • IMNM Nasdaq
  • MATV Nasdaq
  • Market Cap
  • IMNM 747.7M
  • MATV 659.1M
  • IPO Year
  • IMNM 2020
  • MATV 1995
  • Fundamental
  • Price
  • IMNM $12.01
  • MATV $11.68
  • Analyst Decision
  • IMNM Strong Buy
  • MATV Hold
  • Analyst Count
  • IMNM 5
  • MATV 1
  • Target Price
  • IMNM $28.60
  • MATV $15.50
  • AVG Volume (30 Days)
  • IMNM 803.1K
  • MATV 421.7K
  • Earning Date
  • IMNM 11-13-2024
  • MATV 11-06-2024
  • Dividend Yield
  • IMNM N/A
  • MATV 3.34%
  • EPS Growth
  • IMNM N/A
  • MATV N/A
  • EPS
  • IMNM N/A
  • MATV 1.97
  • Revenue
  • IMNM $10,129,000.00
  • MATV $1,974,800,000.00
  • Revenue This Year
  • IMNM N/A
  • MATV $1.88
  • Revenue Next Year
  • IMNM N/A
  • MATV $2.37
  • P/E Ratio
  • IMNM N/A
  • MATV $6.04
  • Revenue Growth
  • IMNM N/A
  • MATV N/A
  • 52 Week Low
  • IMNM $7.76
  • MATV $10.78
  • 52 Week High
  • IMNM $30.96
  • MATV $19.96
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 43.70
  • MATV 39.30
  • Support Level
  • IMNM $12.99
  • MATV $11.80
  • Resistance Level
  • IMNM $15.13
  • MATV $12.37
  • Average True Range (ATR)
  • IMNM 0.93
  • MATV 0.47
  • MACD
  • IMNM -0.16
  • MATV 0.05
  • Stochastic Oscillator
  • IMNM 3.79
  • MATV 22.44

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.

About MATV Mativ Holdings Inc.

Mativ Holdings Inc is a diversified producer of premium specialty papers and resin-based products. It manufactures and sells paper and reconstituted tobacco products to the tobacco industry as well as specialized paper products. The company operates in two segments namely Advanced Materials and Structures, which manufactures resin-based products used in specialty applications in the filtration, infrastructure and construction, transportation, industrial, and medical end-markets, and Engineered Papers, which produces cigarette papers and reconstituted tobacco products for cigarette and cigar manufacturers, as well as various other non-tobacco paper products.

Share on Social Networks: